Key risks
Margin compression: OPM fell sharply from 20.4% (Sep 2025) to 7-10% (Mar-Jun 2026); verify root cause (cost inflation, pricing pressure, or product mix) and whether decline is temporary or structural
Valuation-profitability mismatch: PE of 29.08 with stock down 42.59% in 1y despite ROE of 17.97%; verify if high multiple reflects unachieved recovery targets or if sector headwinds justify the rerating
Earnings deterioration: Net profit fell from ₹90.71 Cr (Sep 2025) to ₹30-51 Cr range (Dec 2025-Jun 2026); verify if decline reflects temporary cycle or operational issues
Valuation cushion: High PE of 29.08 leaves minimal room for earnings disappointment given margin compression from prior-year levels
Generated analysis · source review pending